1 |
Peng SQ, Zhu XR, Zhao MZ, Zhang YF, Wang AR, Chen MB, Ye ZY. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer. Cell Death Dis 2023;14:157. [PMID: 36828810 DOI: 10.1038/s41419-023-05684-5] [Reference Citation Analysis]
|
2 |
Chen M, Li Z, Gu C, Zheng H, Chen Y, Cheng L. Identification of G protein subunit alpha i2 as a promising therapeutic target of hepatocellular carcinoma. Cell Death Dis 2023;14:143. [PMID: 36805440 DOI: 10.1038/s41419-023-05675-6] [Reference Citation Analysis]
|
3 |
Katz LS, Argmann C, Lambertini L, Scott DK. T3 and glucose increase expression of phosphoenolpyruvate carboxykinase (PCK1) leading to increased β-cell proliferation. Mol Metab 2022;66:101646. [PMID: 36455788 DOI: 10.1016/j.molmet.2022.101646] [Reference Citation Analysis]
|
4 |
Zhou L, Peng S, Chen X, Zhu X, Jin A, Liu Y, Zhu L, Zhu Y. Triptonide Inhibits the Cervical Cancer Cell Growth via Downregulating the RTKs and Inactivating the Akt-mTOR Pathway. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/8550817] [Reference Citation Analysis]
|
5 |
Zhu X, Zhu J, Chen Y, Liu Y, Lu J, Sun J, Peng S, Chen M, Du Y. Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma. Front Oncol 2022;12:972744. [DOI: 10.3389/fonc.2022.972744] [Reference Citation Analysis]
|
6 |
Yao J, Wu XY, Yu Q, Yang SF, Yuan J, Zhang ZQ, Xue JS, Jiang Q, Chen MB, Xue GH, Cao C. The requirement of phosphoenolpyruvate carboxykinase 1 for angiogenesis in vitro and in vivo. Sci Adv 2022;8:eabn6928. [PMID: 35622925 DOI: 10.1126/sciadv.abn6928] [Reference Citation Analysis]
|
7 |
Rangwala AM, Mingione VR, Georghiou G, Seeliger MA. Kinases on Double Duty: A Review of UniProtKB Annotated Bifunctionality within the Kinome. Biomolecules 2022;12:685. [DOI: 10.3390/biom12050685] [Reference Citation Analysis]
|
8 |
Yin DP, Zheng YF, Sun P, Yao MY, Xie LX, Dou XW, Tian Y, Liu JS. The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma. Cell Death Dis 2022;13:210. [PMID: 35246508 DOI: 10.1038/s41419-022-04637-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|